No Data
No Data
Well Lead Medical (603309.SH): Subsidiary obtains the operation permit for medical instruments.
Gelonghui September 26th | Well Lead Medical (603309.SH) announced that its holding subsidiary, Well Lead Jianyi (Ji'an) Medical Equipment Co., Ltd. (referred to as "Ji'an Jianyi", with the company holding 70% stake), recently received the "Medical Device Operation Permit" issued by the Ji'an City Market Supervision Administration. After receiving the "Medical Device Operation Permit", Ji'an Jianyi can carry out all medical device wholesale business within its scope of operation. The acquisition of the above certificate will not have a significant impact on the company's operational performance.
Well Lead Medical Gets EU Device Certification for Catheters, Tubes
Well Lead Medical (603309.SH): Product urethral dilator obtains certification from the Canadian Ministry of Health.
Well Lead Medical (603309.SH) announced on August 23rd that it has recently received a Class 2 Medical Instrument Product Registration Certificate issued by the Canadian Ministry of Health. The company's product, the urethral dilator, has obtained certification from the Canadian Ministry of Health. This certification indicates that it can be legally sold in the Canadian market and plays a positive role in the promotion and sales of the product in overseas markets.
Currently, all products of Well Lead Medical (603309.SH) are operating at close to full capacity.
Recently, during a visit with institutional investors, Well Lead Medical (603309.SH) stated that all of its main products' production capacity is currently concentrated domestically, with production bases in five cities. There are two factories in the company's Guangzhou headquarter, which mainly produce anesthesia, urology, nursing, and respiratory products. The Haikou factory mainly produces urinary catheters, the Zhangjiagang factory mainly produces hemodialysis products, the Suzhou factory mainly produces pain pumps, and the Ji'an factory in Jiangxi Province mainly produces male urological products. The company has been continuously optimizing production capacity and upgrading to automated production. Currently, the capacity utilization rate of all the company's products is high.
Well Lead Medical's 2024 interim report: Financially sound, with sustained business growth.
This financial report was announced on 2024-07-26 10:25:57. Well Lead Medical (stock code: 603309) is a company mainly engaged in the research and development, production and sales of medical equipment in the fields of anesthesia, urethral catheterization, urology, nursing, respiratory, hemodialysis and other fields. Its products are widely used in clinical scenarios such as open surgery, minimally invasive surgery, emergency treatment, and nursing. From the asset and liability data, Well Lead Medical's total assets reached 2.775 billion yuan at the end of the reporting period, an increase of 6.50% compared to the beginning of the period, showing the steady growth of the company's assets. Liabilities amounted to 0.985 billion yuan, assets and liabilities
Full text of Well Lead Medical's H1 2024 report.
No Data
No Data